| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.45 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.22 | 0.03 |